Understanding how RNA regulation affects Chronic Obstructive Pulmonary Disease
Post-transcriptional regulatory networks in Chronic Obstructive Pulmonary Disease
['FUNDING_R01'] · UNIVERSITY OF VIRGINIA · NIH-11022330
This study is looking at how certain proteins that interact with RNA might affect the way your body handles Chronic Obstructive Pulmonary Disease (COPD), with the hope of finding new ways to understand and treat the condition.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF VIRGINIA (nih funded) |
| Locations | 1 site (CHARLOTTESVILLE, UNITED STATES) |
| Trial ID | NIH-11022330 on ClinicalTrials.gov |
What this research studies
This research investigates the role of post-transcriptional regulation of RNA in Chronic Obstructive Pulmonary Disease (COPD). By examining how RNA binding proteins (RBPs) interact with RNA molecules, the study aims to uncover the molecular mechanisms that contribute to COPD. The researchers will analyze changes in RNA levels and their impact on protein function, using advanced techniques to create regulatory networks specific to COPD. This approach could lead to a better understanding of the disease and potential new therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Chronic Obstructive Pulmonary Disease.
Not a fit: Patients with other respiratory conditions that are not COPD may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve the management of COPD and enhance patient outcomes.
How similar studies have performed: Previous research has shown promising results in understanding RNA regulation in other diseases, suggesting that this approach could yield valuable insights for COPD as well.
Where this research is happening
CHARLOTTESVILLE, UNITED STATES
- UNIVERSITY OF VIRGINIA — CHARLOTTESVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PLATIG, JOHN — UNIVERSITY OF VIRGINIA
- Study coordinator: PLATIG, JOHN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.